PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 43 filers reported holding PLX PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 1,875,000 | $7,575,000 | 0.41% |
| Ground Swell Capital, LLC | 31,150 | $126,000 | 0.32% |
| Park West Asset Management LLC | 1,473,218 | $5,952,000 | 0.21% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $253,000 | 0.13% |
| O'Brien Greene & Co. Inc | 60,340 | $244,000 | 0.08% |
| Eidelman Virant Capital | 27,000 | $109,000 | 0.06% |
| MBL Wealth, LLC | 52,000 | $210,000 | 0.05% |
| Shay Capital LLC | 88,620 | $358,000 | 0.05% |
| EXANE DERIVATIVES | 13,407 | $54,161,000 | 0.02% |
| GW&K Investment Management, LLC | 428,171 | $1,730,000 | 0.02% |